NOVUS ACQSTN DEV (NDEV) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 129 215 sessions, October 13, 2025 to October 13, 2026
- Largest daily move
- +58.3% close of October 31, 2025
- 1-year change
- -6% closing prices, October 13, 2025 to October 13, 2026
- 1-month change
- +35.3% closing prices, September 11, 2026 to October 13, 2026
Company Description
NOVUS ACQSTN DEV (OTC: NDEV) is classified in the insurance - diversified industry within the Financial Services sector and carries a market capitalization of $2.4M.
NDEV has declined 6.0% over the past year. The last closing price was $0.0188.
This page collects what Stock Titan holds for NDEV, including price data, latest news, and short interest trends.
Stock Performance
NOVUS ACQSTN DEV (NDEV) closed at $0.0188 on October 13, 2026. Over the past 12 months, the price has lost 6.0%.
NDEV Metrics & Rankings
Price returns through October 13, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NOVUS ACQSTN DEV has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, partnership, acquisition. View all NDEV news →
SEC Filings
Short Interest History
Short interest in NOVUS ACQSTN DEV (NDEV) currently stands at 184 shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since February 2026, short interest has increased by 253.8%.
Days to Cover History
Days to cover for NOVUS ACQSTN DEV (NDEV) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
NDEV Company Profile & Sector Positioning
NOVUS ACQSTN DEV (NDEV) operates in the Insurance - Diversified industry within the broader Financial Services sector and is listed on the OTC.
Investors comparing NDEV often look at related companies in the same sector, including IDEAL GROUP OF COMPANIES (IDGR), MARKETING ALLIANCE INC (MAAL), ADIA MED INC (ADIA), METAVESCO INC. (MVCO), and ACMAT CORP A (ACMTA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NDEV's relative position within its industry.